Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) shares dropped 6% on Thursday . The company traded as low as $0.47 and last traded at $0.47. Approximately 500 shares changed hands during trading, a decline of 98% from the average daily volume of 20,342 shares. The stock had previously closed at $0.50.
Cell MedX Stock Down 6.0 %
The firm’s 50 day moving average is $0.34 and its two-hundred day moving average is $0.13.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Featured Stories
- Five stocks we like better than Cell MedX
- What Investors Need to Know to Beat the Market
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Stock Sentiment Analysis: How it Works
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Why Invest in 5G? How to Invest in 5G Stocks
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
